Jag Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jag Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,450	Closed	-$1.33M	–	191
2022 Q3	$1.33M	Sell	21,450 -160,287	-88%	-$11.2M	0.19%	90
2022 Q2	$14.5M	Buy	+181,737	New	+$17.2M	1.79%	16
2022 Q1	–	Sell	-193,200	Closed	-$20.8M	–	269
2021 Q4	$20.8M	Sell	193,200 -4,535	-2%	-$495K	1.6%	23
2021 Q3	$21.7M	Buy	+197,735	New	+$20.5M	1.69%	22

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jag Capital Management's HZNP Position: Q4 2022 in Review

Jag Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2022, closing a stake of 21,450 shares — an estimated $1.33M sold.

Jag Capital Management first reported a position in HZNP in Q3 2021 and held it in 4 quarters. The position peaked at $21.7M in Q3 2021. 615 funds tracked by Wall St. Rank hold HZNP as of Q4 2022.

Jag Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Jag Capital Management sold 21,450 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2022, an estimated $1.33M.
Jag Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2021 and held it in 4 quarters.
Jag Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $21.7M in Q3 2021.
615 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2022.

Based on Jag Capital Management's 13F filing for Q4 2022, filed 8 Feb 2023.